USE OF ANTIBIOTICS WITH SPECIFIC THERAPEUTIC ACTIVITIES IN COMBINATION WITH SIMULTANEOUS USE OF LACTOBACILLI AND/OR BIFIDOBACTERIA WITH NON-TRANSIENT RESISTANCE TO ANTIBIOTICS HAVING THE SAME THERAPEUTIC VALUE Russian patent published in 2020 - IPC A61K31/395 A61P1/06 C12N1/00 

Abstract RU 2737891 C2

FIELD: pharmaceutical industry.

SUBSTANCE: present invention relates to the use of an antibiotic with specific therapeutic indications in an effective amount in association with a bifidobacteria strain. Using an antibiotic with specific therapeutic indications in an effective amount in association with a bifidobacteria strain, where said bifidobacteria strain exhibits resistance to an antibiotic not transmitted to other species, and is also used for the same therapeutic indications as said antibiotic for treating diseases, selected from: acute and chronic intestinal infections caused by gram-positive and gram-negative bacteria; diarrheal syndromes; diarrhea caused by intestinal microflora imbalance, selected from summer diarrhea, travelers' diarrhea and enterocolitis; for pre- and postoperative prevention of infectious complications in gastrointestinal surgery; gastrointestinal disorders, such as irritable bowel syndrome (IBS), constipation and changes of intestinal microflora; chronic inflammatory intestinal diseases (CIID) (also known as inflammatory bowel diseases (IBD)), which include Crohn's disease and ulcerative rectocolitis; and Helicobacter pylori infections, wherein said antibiotic is selected from a group consisting of rifamycin and rifaximin, where said bifidobacteria strain is Bifidobacterium longum W11, access number LMG P-21586 deposited in the Belgian coordinated collection of microorganisms BCCM LMG, where said strain has concentration of 1×109 to 1×1012 live cells per gram of said strain, where bacteria are coated with a protein matrix, wherein said antibiotic is administered simultaneously with bacterial strain Bifidobacterium longum W11 LMG P-21586 and wherein said antibiotic and said bacterial strain are administered individually or in one composition.

EFFECT: what is presented is the use of antibiotics with specific therapeutic activities combined with simultaneous application of lactobacilli and/or bifidobacteria with persistent resistance to antibiotics, having the same therapeutic value.

6 cl, 2 tbl

Similar patents RU2737891C2

Title Year Author Number
PROBIOTIC STRAIN OF Bifidobacterium longum, COMPOSITION CONTAINING SUCH STRAIN AND USE THEREOF 2008
  • Maksherri Dzhon
  • O'Makhouni Lajam
  • O'Sallivan Dehvid
  • K'Eli Barri
RU2473681C2
PROBIOTIC STRAIN Bifidobacterium longum, PROBIOTIC COMPOSITION AND USE OF STRAIN Bifidobacterium longum 2008
  • Maksherri Dzhon
  • O'Makhouni Lajam
  • O'Sallivan Dehvid
  • K'Eli Barri
RU2466185C2
STRAIN BIFIDOBACTERIUM LONGUM INFANTIS FOR PROBIOTIC PRODUCTION, ANTI-MICROBIAL AGENT AND PREPARATION BASED ON STRAIN BIFIDOBACTERIUM LONGUM INFANTIS WITH IMMUNOMODULATING PROPERTIES 2000
  • Kollinz Dzhon Kevin
  • O`Sallivan Dzherald Kristofer
  • O`Maoni Lajehm
  • Shehnehkhehn Fergus
RU2308483C2
POLYSACCHARIDE FROM Bifidobacterium infantis STRAIN AND USE THEREOF TO TREAT OR PREVENT INFLAMMATORY DISORDERS 2008
  • Grant Rejmond Alan
  • O'Makhouni Lajam
  • Shejl Barbara
RU2511044C2
APPLICATION OF BIFIDOBACTERIUM LONGUM IN PRODUCTION OF MEDICINAL AGENT OR THERAPEUTIC NUTRIENT COMPOSITION FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE IN MAMMAL AND FOR SUPPRESSION OF BOWEL INFLAMMATION RELATED TO FOOD ALLERGENS, IN MAMMAL 2007
  • Mersen'Er Annik
  • Bljum-Sperizen Stefani
  • Rosha Florans
RU2445362C2
PROBIOTIC STRAIN OF BIFIDUS BACTERIA 2010
  • O'Mahony Liam
  • Kiely Barry
  • Chyan John Frabcis
  • Dinan Timothy
  • Murphy Eileen Frances
RU2546251C2
NON-VIABLE BACTERIA BIFIDOBACTERIUM BIFIDUM AND THEIR USE 2019
  • Fischer, Clemens
RU2800878C2
ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON BACTERIAL STRAIN 2015
  • Alekhina Galina Gennadievna
  • Danilenko Valerij Nikolaevich
  • Ermolenko Elena Igorevna
  • Klimina Kseniya Mikhajlovna
  • Poluektova Elena Ulrikhovna
  • Ratkin Anatolij Vasilevich
  • Suvorov Aleksandr Nikolaevich
RU2616899C1
USE OF MICROBIAL COMMUNITIES FOR THE TREATMENT OF HUMANS AND ANIMALS 2017
  • Posseme Sem
  • Marzorati Massimo
  • Van De Vile Tom
  • Skhejrlink Ilse
  • Van Den Abele Piter
  • Bolka Selin
  • Gottardi David
RU2758387C2
Lactococcus lactis STRAIN FOR TREATMENT OR PREVENTION OF DIGESTION DISORDER AND THEREOF APPLICATION 2010
  • Lezik Bil'Jana
  • Shambo Izabell'
RU2567009C2

RU 2 737 891 C2

Authors

Mogna Giovanni

Dates

2020-12-04Published

2016-04-29Filed